Heska

Heska FCF Margin

Delisted

The Free Cash Flow Margin of Heska (HSKA) as of Nov 2, 2026 is -9.30 %. In the previous year, Free Cash Flow Margin was 1.77 % — a change of -626.80% (lower).

FCF Margin

-9.30 %

YoY

-626.80%

Last updated:

Free Cash Flow Margin of Heska is 2022 -9.30 % . Free Cash Flow Margin of Heska was 2021 1.77 % . It decreases by -626.80% lower compared to the previous year.

The Heska FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2015
-1.58 USD
Jan 1, 2016
1.87 USD
Jan 1, 2017
5.37 USD
Jan 1, 2018
7.20 USD
Jan 1, 2019
1.84 USD
Jan 1, 2020
-0.68 USD
Jan 1, 2021
1.77 USD
Jan 1, 2022
-9.30 USD
The Heska FCF Margin history
YEARFCF MarginYoY
-9.30 %-626.80%
1.77 %-359.55%
-0.68 %-137.04%
1.84 %-74.51%
7.20 %+34.23%
5.37 %+186.29%
1.87 %-218.95%
-1.58 %-141.09%
3.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heska Stock analysis

What does Heska do? Heska Corp was founded in 2001 and has since become a leading company in the field of animal health. The company is headquartered in Loveland, Colorado and has locations in the USA, Europe, and Asia. Heska's business model is based on the development, manufacturing, and marketing of innovative diagnostic and therapeutic products for animals. The company aims to provide veterinarians and pet owners with a comprehensive range of solutions to support the health and well-being of animals. Heska has divided itself into three main divisions in order to cover the entire spectrum of animal health: diagnosis, therapy, and traceability. In the "diagnosis" division, Heska offers a wide range of diagnostic test kits for various animals, including dogs, cats, horses, cattle, and pigs. The tests include blood tests, urine tests, imaging tests, and molecular diagnostics. Heska's therapy division includes products for the treatment of animals, including medications, vaccines, and pet conditioners. The company also develops innovative therapy approaches to combat diseases in animals, including oncology. Another important aspect of Heska's business model is offering targeted solutions for seamless traceability of animals for agricultural and veterinary purposes. The company offers a wide selection of animal identification products that are known for their reliability and safety. Heska is committed to continuously improving and innovating its products to help animals and pet owners worldwide. The company aims to achieve better access to healthcare for animals through its research and development in the field of animal health, thus improving the lives of all animals. In summary, Heska Corp is a significant company in the field of animal health that specializes in the development and marketing of diagnostic and therapeutic products for animals. The company's products are valued by veterinarians and pet owners worldwide and contribute to improving the health and well-being of animals. Heska is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Heska stock

Free Cash Flow Margin of Heska is -9.30 % in 2022.

Free Cash Flow Margin of Heska changed from 1.77 % to -9.30 %, representing a -626.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Heska since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Heska with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Heska

All Key Metrics — Heska